LI vs PPCB · P/E 24, rev $16.06B vs P/E 0.0, $3.9M cap
Li Auto Inc (LI) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Li Auto Inc (LI) is a auto manufacturers company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
PPCB does not have a complete income-statement cache yet.
LI currently screens at market cap $26.62B and trailing P/E 24.2. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the LI and PPCB stock pages for the full models.
Not investment advice.